Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-121-9 | CAS number: 20941-65-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- yes
- Test type:
- traditional method
- Limit test:
- no
Test material
- Reference substance name:
- Tetrakis(diethyldithiocarbamato-S,S')tellurium
- EC Number:
- 244-121-9
- EC Name:
- Tetrakis(diethyldithiocarbamato-S,S')tellurium
- Cas Number:
- 20941-65-5
- Molecular formula:
- C20H40N4S8Te
- IUPAC Name:
- N2,N2,N6,N6,N6,N6,N9,N9-octaethyl-1λ³,3,5λ³,5λ³,7,7,8λ³,10-octathia-4λ⁸-telluradispiro[3.3⁴.3⁴.3⁴]trideca-1,5,5,8-tetraene-2,6,6,9-tetramine
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- - Name of the test item (as cited in study report): Tellurium diethyldithiocarbamate
- Batch No.: MT-5D-494
- Appearance: Yellow, crystalline
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Manston Road, Margate, Kent, England, obtained on 1 November 1985
- Weight at study initiation: 133 - 190g
- Age at study initiation: 8-9 weeks
- Housing:
- polypropylene cage (size 38 x 56 cm x 18 cm height) per 10 rats (5 males and 5 females) before exposure
- Stainless steel mesh cage (30.5 x 19 x 20 cm height) per rat
- Diet: Labsure LAD 1 (ad libitum)
- Water: tap water (ad libitum)
ENVIRONMENT
- Temperature: 19.4 - 21.3 °C
- Humidity: 42%
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- > 5.5 µm
- Details on inhalation exposure:
- PROCEDURE
A sample of the test substance was packed into the container of the Wright dust generator using a hydraulic bench press to assist packing. Even density of the powder was achieved by packing the container in stages and applying a force of 0.4 tons weight. The packed container was weighed.
The dust generator was positioned on a stand at the side of the exposure chamber and the output connected to an inlet port in the top centre of the chamber by the aerosol neutraliser.
The gear ratio of the generator mechanism was set to give the highest possible concentration of dust.
A supply of clean, dried compressed air was connected to the dust generator and the supply pressure was adjusted to give a flow rate of 25 litres per minute measured at the generator outlet nozzle. The total chamber air supply was derived from the air flow through the dust generator.
The rats (5 males and 5 females) were placed into separate compartments of the exposure chamber.
The powder container of the Wright dust generator was advanced manually until a trace of suspended dust was in the chamber. The gearing on the generator was then engaged and the generator motor switched on to start the exposure. After a 12-minute equilibration period, the exposure was timed for 4 hours. The generator was then switched off and the chamber allowed to clear before the rats were removed for examination.
The rats were placed into individual cages and returned to the holding room for the remainder of the observation period. The rack containing the cages was placed in a ventilated cabinet drawing its air supply from the holding room.
The control group was treated similarly but received clean air only for 4 hours.
CHAMBER ATMOSPHERE ANALYSES
Eight air samples were taken from a sampling port in the chamber during exposure and weighed to determine the concentration of the test substance in the chamber air.
A further 4 samples were taken from a second sampling port in a different wall of the chamber to check the spatial distribution of the test material.
The samples were drawn through a weighed Whatman GF/A glass fibre filter, mounted in an open face filter holder, at a rate of 4 litres per minute. The volume of the air sample was measured with a wet-type gas meter.
Four further air samples were taken using an Andersen mini-sampler (Andersen 2000 Inc.) and the collected material was weighed to determine the particle size distribution of the test substance.
At a sampling rate of 1.4 litres per minute the collection characteristics of the Andersen sampler are:
Stage 1 - Particles larger than 5.5 µm aerodynamic diameter (a .d.)
Stage 2 - Particles between 3.5 µm and 5.5 µm a.d.
Stage 3 - Particles between 2.0 µm and 3.5 µm a.d.
Stage 4 - Particles between 0.3 µm and 2.0 µm a.d.
Filter - Particles smaller than 0.3 µm a.d. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Nominal: 17.7 mg/L
Analtycial: 0.51 mg/L (30% respirable) - No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of examination: The rats were observed continuously during exposure, hourly for 4 hours following exposure and at least twice daily throughout the observation period. All rats were weighed on Days 1 (before exposure), 2, 3, 5, 8, 11 and 15.
- Necropsy of survivors performed: Yes
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 0.51 mg/L air
- Based on:
- test mat.
- Mortality:
- There were no deaths during this study
- Clinical signs:
- other: During the exposure period, some animals showed partial closing of the eyes and labored breathing. This is considered a non specific effect to dust-exposure. During the observation period, some animals showed an abnormal respiratory pattern for 3 hours fo
- Body weight:
- Small losses of bodyweight or a reduction in the rate of weight gain on the day following exposure. Normal from Day 5.
- Gross pathology:
- No treatment-related abnormalities.
Any other information on results incl. tables
CHAMBER ATMOSPHERE CONDITIONS
Concentration of test substance
The mass concentrations of the test substance in the air samples taken during the exposure were:
Sample |
Time taken |
Concentration in air (mg/L) |
2.1 |
0 h : 20 m |
0.27 |
2.2 |
0 h : 50 m |
0.45 |
2.3 |
1 h : 30 m |
0.62 |
2.4 |
1 h : 50 m |
0.57 |
2.5 |
2 h : 20 m |
0.53 |
2.6 |
2 h : 50 m |
0.52 |
2.7 |
3 h : 20 m |
0.55 |
2.8 |
3 h : 50 m |
0.57 |
Mean: 0.51
Standard deviation: 0.109
The results for the samples taken from a second sampling port were 0.15, 0.49, 0.58 and 0.64 mg/L for samples taken at 0 h 25 m, 1 h 35 m, 2 h 35 m and 3 h 25 m respectively. The samples were similar to those of the main series taken at approximately the same times showing that spatial distribution within the chamber was acceptable. The low values at 0 h 20 m and 0 h 25 m were due to technical difficulties with the generator.
Nominal concentration
The nominal concentration determined by dividing the total test substance used by the total airflow was 17.7 mg/L.
Particle size distribution
The analysis results for the air samples taken for the determination of particle size distribution are given in TABLE 1. The results show that, on average, 30% by weight, of the test substance in the chamber air was 5.5 µm or less in aerodynamic diameter and therefore of respirable size.
Sample |
Time taken |
Stage |
Particle size (µm) |
Amount in stage (mg) |
% of total |
% respirable |
PSD 1 |
0 h : 55 m |
1 2 3 4 Filter |
> 5.5 3.5-5.5 2.0-3.5 0.3-2.0 <0.3 Total |
3.99 1.18 0.42 0.20 0.01 5.80 |
68.8 20.3 7.2 3.4 0.2 |
31.2 |
PSD 2 |
1 h : 55 m |
1 2 3 4 Filter |
> 5.5 3.5-5.5 2.0-3.5 0.3-2.0 <0.3 Total |
4.24 1.01 0.41 0.15 0.06 5.87 |
72.2 17.2 7.0 2.6 1.0 |
27.8 |
PSD 3 |
2 h : 55 m |
1 2 3 4 Filter |
> 5.5 3.5-5.5 2.0-3.5 0.3-2.0 <0.3 Total |
3.06 0.95 0.32 0.13 0.04 4.50 |
68.0 21.1 7.1 2.9 0.9 |
32.0 |
PSD 4 |
3 h : 52 m |
1 2 3 4 Filter |
> 5.5 3.5-5.5 2.0-3.5 0.3-2.0 <0.3 Total |
3.91 0.98 0.35 0.17 0.07 5.48 |
71.4 17.9 6.4 3.1 1.3 |
28.6 |
Mean respirable: 29.9%
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- The study determined a LC50 of > 0.51 mg/L, which was the highest concentration that could be generated. In order to achieve applicability of animal experiments to human exposure, the mean mass aerodynamic diameter (MMAD) should be low enough to ensure that the test substance will deposit in all regions of the rats respiratory tract of the appropriate test animal. According to OECD TG 403, the primary goal should be to achieve a MMAD of 1 - 4 µm when testing aerosols. In the study, particle size distribution analysis showed that the majority of the test substance exceeds a particle size of 5.5 µm during exposure. Because of the low efficiency of generation (measured concentration was only 2.9% of the nominal concentration) and the relative large particle size, data cannot be used for classification of acute inhalation toxicity. As sufficient data are available on the other two routes of exposure, the study is not warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
